- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
| Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
|---|---|---|---|---|---|---|
| Medical Manager | INSURGENTES | Mexico | International | Innovative Medicines | Research & Development | Jan 03, 2025 |
| Expert Scientific Writer | Hyderabad (Office) | India | Operations | Innovative Medicines | Research & Development | Jan 03, 2025 |
| Expert Scientific Writer | Hyderabad (Office) | India | Operations | Innovative Medicines | Research & Development | Jan 03, 2025 |
| Expert Scientific writer | Hyderabad (Office) | India | Operations | Innovative Medicines | Research & Development | Jan 03, 2025 |
| Expert Scientific Writer | Hyderabad (Office) | India | Operations | Innovative Medicines | Research & Development | Jan 03, 2025 |
| Senior Scientific Engagement and Program Manager | Hyderabad (Office) | India | Operations | Innovative Medicines | Research & Development | Jan 03, 2025 |
| Field Medical Trial Acceleration Director | Field Non-Sales (USA) | USA | US | Innovative Medicines | Research & Development | Jan 03, 2025 |
| RA CMC Senior Manager | Hyderabad (Office) | India | Development | Innovative Medicines | Research & Development | Jan 02, 2025 |
| SSO Study Start Up Country Head | London (The Westworks) | United Kingdom | Development | Innovative Medicines | Research & Development | Jan 02, 2025 |
| Global Program Clinical Head Neuroscience (MD, PHD) | East Hanover | USA | Development | Innovative Medicines | Research & Development | Jan 02, 2025 |
| Senior Scientific Engagement and Program Manager | Hyderabad (Office) | India | Operations | Innovative Medicines | Research & Development | Jan 02, 2025 |
| Senior Project Manager | Hyderabad (Office) | India | Operations | Innovative Medicines | Research & Development | Jan 02, 2025 |
| MSL Manager, IMMU | Shanghai (Shanghai) | China | International | Innovative Medicines | Research & Development | Jan 02, 2025 |
| Medical Information Manager | Shanghai (Shanghai) | China | International | Innovative Medicines | Research & Development | Jan 02, 2025 |
| Medical Science Liaison, Immunology | Beijing (Beijing) | China | International | Innovative Medicines | Research & Development | Jan 02, 2025 |
| Medical Science Liaison, Immunology | Shenyang (Liaoning Province) | China | International | Innovative Medicines | Research & Development | Jan 02, 2025 |
| Medical Science Liaison, Immunology | Jinan (Shandong Province) | China | International | Innovative Medicines | Research & Development | Jan 02, 2025 |
| Medical Science Liaison, Immunology | Beijing (Beijing) | China | International | Innovative Medicines | Research & Development | Jan 02, 2025 |
| Medical Safety Expert | Hyderabad (Office) | India | Development | Innovative Medicines | Research & Development | Jan 01, 2025 |
| Scientific Writer II | Hyderabad (Office) | India | Operations | Innovative Medicines | Research & Development | Jan 01, 2025 |
| Senior Scientific Writer I | Hyderabad (Office) | India | Operations | Innovative Medicines | Research & Development | Jan 01, 2025 |
| Senior Scientific Writer II | Hyderabad (Office) | India | Operations | Innovative Medicines | Research & Development | Jan 01, 2025 |
| Principal Biostatistician | Shanghai (Shanghai) | China | Development | Innovative Medicines | Research & Development | Jan 01, 2025 |
| RA Head India | Mumbai (Head Office) | India | Development | Sandoz | Research & Development | Dec 31, 2024 |
| Medical Science Liaison, Immunology | Nanjing (Jiangsu Province) | China | International | Innovative Medicines | Research & Development | Dec 29, 2024 |
| Medical Science Liaison, Immunology | Shanghai (Shanghai) | China | International | Innovative Medicines | Research & Development | Dec 29, 2024 |
| Medical Science Liaison, Immunology | Hangzhou (Zhejiang Province) | China | International | Innovative Medicines | Research & Development | Dec 29, 2024 |
| Medical Science Liaison, Immunology | Changsha (Hunan Province) | China | International | Innovative Medicines | Research & Development | Dec 29, 2024 |
| Medical Science Liaison, Immunology | Chengdu (Sichuan Province) | China | International | Innovative Medicines | Research & Development | Dec 26, 2024 |
| Medical Science Liaison, Immunology | Xi an (Shaanxi Province) | China | International | Innovative Medicines | Research & Development | Dec 26, 2024 |
| Medical Science Liaison, Immunology | Fuzhou (Fujian Province) | China | International | Innovative Medicines | Research & Development | Dec 26, 2024 |
| Medical Science Liaison, Immunology | Shenzhen (Guangdong Province) | China | International | Innovative Medicines | Research & Development | Dec 26, 2024 |
| Medical Launch Liason-RLT | Hangzhou (Zhejiang Province) | China | International | Innovative Medicines | Research & Development | Dec 25, 2024 |
| Medical Launch Liason-RLT | Shanghai (Shanghai) | China | International | Innovative Medicines | Research & Development | Dec 25, 2024 |
| Medical Advisor, LC | Shanghai (Shanghai) | China | International | Innovative Medicines | Research & Development | Dec 25, 2024 |
| Senior Scientific/Regulatory Writer | Remote Position (USA) | USA | Development | Innovative Medicines | Research & Development | Dec 24, 2024 |
| Senior Manager , Analytical Development Laboratory | Hyderabad (Office) | India | Development | Innovative Medicines | Research & Development | Dec 23, 2024 |
| Associate Director, xRNA Therapeutics | Cambridge (USA) | USA | Biomedical Research | Pharma Research | Research & Development | Dec 23, 2024 |
| RA Manager | Istanbul Ataşehir | Türkiye | Development | Innovative Medicines | Research & Development | Dec 23, 2024 |
| Medical Advisor, Cardio | Shanghai (Shanghai) | China | International | Innovative Medicines | Research & Development | Dec 23, 2024 |
| Medical Unit Director Cardiovascular (f/m/d) | Munich (Non-Sales Force) (Novartis Pharma GmbH) | Germany | International | Innovative Medicines | Research & Development | Dec 22, 2024 |
| Expert Science & Technology – Trace level analytics (e.g. nitrosamines, genotoxic impurities) | Basel (City) | Switzerland | Development | Innovative Medicines | Research & Development | Dec 21, 2024 |
| Clinical Research Medical Advisor (m/f/d) - Cardio-Renal-Metabolism | Barcelona Gran Vía | Spain | Development | Innovative Medicines | Research & Development | Dec 20, 2024 |
| Medical Science Liaison | Guatemala | Guatemala | International | Innovative Medicines | Research & Development | Dec 20, 2024 |
| Hematology MSL | INSURGENTES | Mexico | International | Innovative Medicines | Research & Development | Dec 20, 2024 |
| Spécialiste, Sécurité des patients | Montreal | Canada | International | Innovative Medicines | Research & Development | Dec 20, 2024 |
| Medical Lead Solid Tumors | Santiago | Chile | International | Innovative Medicines | Research & Development | Dec 20, 2024 |
| GCO Budget Manager | London (The Westworks) | United Kingdom | Development | Innovative Medicines | Research & Development | Dec 20, 2024 |
| Medical Director, Renal | London (The Westworks) | United Kingdom | Development | Innovative Medicines | Research & Development | Dec 20, 2024 |
| Medical Lead | Lima (Pharmaceuticals / GDD / CTS) | Peru | International | Innovative Medicines | Research & Development | Dec 20, 2024 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى